A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098Nicholas F. Brown, Paul Mulholland, Hendrik‐Tobias Arkenau et al.|Neuro-Oncology|2018Cited by 83